Literature DB >> 20093361

Expression of a homeostatic regulator, Wip1 (wild-type p53-induced phosphatase), is temporally induced by c-Jun and p53 in response to UV irradiation.

Ji-young Song1, Hye-Sook Han, Kanaga Sabapathy, Byung-Moo Lee, Eunsil Yu, Jene Choi.   

Abstract

Wild-type p53-induced phosphatase (Wip1) is induced by p53 in response to stress, which results in the dephosphorylation of proteins (i.e. p38 MAPK, p53, and uracil DNA glycosylase) involved in DNA repair and cell cycle checkpoint pathways. p38 MAPK-p53 signaling is a unique way to induce Wip1 in response to stress. Here, we show that c-Jun directly binds to and activates the Wip1 promoter in response to UV irradiation. The binding of p53 to the promoter occurs earlier than that of c-Jun. In experiments, mutation of the p53 response element (p53RE) or c-Jun consensus sites reduced promoter activity in both non-stressed and stressed A549 cells. Overexpression of p53 significantly decreased Wip1 expression in HCT116 p53(+/+) cells but increased it in HCT116 p53(-/-) cells. Adenovirus-mediated p53 overexpression greatly decreased JNK activity. Up-regulation of Wip1 via the p38 MAPK-p53 and JNK-c-Jun pathways is specific, as demonstrated by our findings that p38 MAPK and JNK inhibitors affected the expression of the Wip1 protein, whereas an ERK inhibitor did not. c-Jun activation occurred much more quickly, and to a greater extent, in A549-E6 cells than in A549 cells, with delayed but fully induced Wip1 expression. These data indicate that Wip1 is activated via both the JNK-c-Jun and p38 MAPK-p53 signaling pathways and that temporal induction of Wip1 depends largely on the balance between c-Jun and p53, which compete for JNK binding. Moreover, our results suggest that JNK-c-Jun-mediated Wip1 induction could serve as a major signaling pathway in human tumors in response to frequent p53 mutation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20093361      PMCID: PMC2838327          DOI: 10.1074/jbc.M109.070003

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Involvement of wild-type p53 in radiation-induced c-Jun N-terminal kinase activation in human thyroid cells.

Authors:  S S Shklyaev; H Namba; Y Sautin; N Mitsutake; Y Nagayama; N Ishikawa; K Ito; K Zeki; S Yamashita
Journal:  Anticancer Res       Date:  2001 Jul-Aug       Impact factor: 2.480

2.  Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23.

Authors:  Jing Li; Ying Yang; Yue Peng; Richard J Austin; Winfried G van Eyndhoven; Ken C Q Nguyen; Tim Gabriele; Mila E McCurrach; Jeffrey R Marks; Timothy Hoey; Scott W Lowe; Scott Powers
Journal:  Nat Genet       Date:  2002-05-20       Impact factor: 38.330

3.  p53 phosphorylation and association with murine double minute 2, c-Jun NH2-terminal kinase, p14ARF, and p300/CBP during the cell cycle and after exposure to ultraviolet irradiation.

Authors:  T Buschmann; V Adler; E Matusevich; S Y Fuchs; Z Ronai
Journal:  Cancer Res       Date:  2000-02-15       Impact factor: 12.701

4.  Loss of Wip1 sensitizes cells to stress- and DNA damage-induced apoptosis.

Authors:  Yun Xia; Pat Ongusaha; Sam W Lee; Yih-Cherng Liou
Journal:  J Biol Chem       Date:  2009-04-24       Impact factor: 5.157

5.  Mice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle control.

Authors:  Jene Choi; Bonnie Nannenga; Oleg N Demidov; Dmitry V Bulavin; Austin Cooney; Cory Brayton; Yongxin Zhang; Innocent N Mbawuike; Allan Bradley; Ettore Appella; Lawrence A Donehower
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

6.  p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation.

Authors:  M Takekawa; M Adachi; A Nakahata; I Nakayama; F Itoh; H Tsukuda; Y Taya; K Imai
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

Review 7.  AP-1 in cell proliferation and survival.

Authors:  E Shaulian; M Karin
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

8.  The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest.

Authors:  E Shaulian; M Schreiber; F Piu; M Beeche; E F Wagner; M Karin
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

9.  Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity.

Authors:  Dmitry V Bulavin; Oleg N Demidov; Shin'ichi Saito; Paivikki Kauraniemi; Crissy Phillips; Sally A Amundson; Concetta Ambrosino; Guido Sauter; Angel R Nebreda; Carl W Anderson; Anne Kallioniemi; Albert J Fornace; Ettore Appella
Journal:  Nat Genet       Date:  2002-05-20       Impact factor: 38.330

10.  Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress.

Authors:  T Buschmann; O Potapova; A Bar-Shira; V N Ivanov; S Y Fuchs; S Henderson; V A Fried; T Minamoto; D Alarcon-Vargas; M R Pincus; W A Gaarde; N J Holbrook; Y Shiloh; Z Ronai
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

View more
  10 in total

1.  Mycobacterium tuberculosis serine protease Rv3668c can manipulate the host-pathogen interaction via Erk-NF-κB axis-mediated cytokine differential expression.

Authors:  Quanju Zhao; Wu Li; Tian Chen; Ying He; Wanyan Deng; Hongping Luo; Jianping Xie
Journal:  J Interferon Cytokine Res       Date:  2014-03-31       Impact factor: 2.607

2.  Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway.

Authors:  Xinna Zhang; Guohui Wan; Sizolwenkosi Mlotshwa; Vicki Vance; Franklin G Berger; Hexin Chen; Xiongbin Lu
Journal:  Cancer Res       Date:  2010-07-28       Impact factor: 12.701

3.  Downregulation of Wip1 phosphatase modulates the cellular threshold of DNA damage signaling in mitosis.

Authors:  Libor Macurek; Jan Benada; Erik Müllers; Vincentius A Halim; Kateřina Krejčíková; Kamila Burdová; Sona Pecháčková; Zdeněk Hodný; Arne Lindqvist; René H Medema; Jiri Bartek
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

4.  NFκB and STAT3 synergistically activate the expression of FAT10, a gene counteracting the tumor suppressor p53.

Authors:  Yongwook Choi; Jong Kyoung Kim; Joo-Yeon Yoo
Journal:  Mol Oncol       Date:  2014-01-24       Impact factor: 6.603

Review 5.  Regulation of the Wip1 phosphatase and its effects on the stress response.

Authors:  Julie Lowe; Hyukjin Cha; Mi-Ok Lee; Sharlyn J Mazur; Ettore Appella; Albert J Fornace
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

Review 6.  Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum.

Authors:  Ahmed Y Ali; Lee Farrand; Ji Young Kim; Sanguine Byun; Jeong-Yong Suh; Hyong Joo Lee; Benjamin K Tsang
Journal:  Ann N Y Acad Sci       Date:  2012-10       Impact factor: 5.691

Review 7.  Protein kinases and transcription factors activation in response to UV-radiation of skin: implications for carcinogenesis.

Authors:  César López-Camarillo; Elena Aréchaga Ocampo; Mavil López Casamichana; Carlos Pérez-Plasencia; Elizbeth Alvarez-Sánchez; Laurence A Marchat
Journal:  Int J Mol Sci       Date:  2011-12-23       Impact factor: 5.923

8.  Feedbacks, Bifurcations, and Cell Fate Decision-Making in the p53 System.

Authors:  Beata Hat; Marek Kochańczyk; Marta N Bogdał; Tomasz Lipniacki
Journal:  PLoS Comput Biol       Date:  2016-02-29       Impact factor: 4.475

9.  Co-targeting WIP1 and PARP induces synthetic lethality in hepatocellular carcinoma.

Authors:  Miaoqin Chen; Weikai Wang; Shiman Hu; Yifan Tong; Yiling Li; Qi Wei; Lei Yu; Liyuan Zhu; Yiran Zhu; Leiming Liu; Zhenyu Ju; Xian Wang; Hongchuan Jin; Lifeng Feng
Journal:  Cell Commun Signal       Date:  2022-03-28       Impact factor: 5.712

Review 10.  Wip1 phosphatase: between p53 and MAPK kinases pathways.

Authors:  Anastasia R Goloudina; Elena Y Kochetkova; Tatyana V Pospelova; Oleg N Demidov
Journal:  Oncotarget       Date:  2016-05-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.